Author/Creator: Lancelotta, Rafael - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Lancelotta, Rafael

1. 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. (4th March 2019)

Authors:: Davis, Alan K.; So, Sara; Lancelotta, Rafael; Barsuglia, Joseph P.; Griffiths, Roland R.
Journal:: American journal of drug and alcohol abuse
Issue:: Volume 45:Number 2(2019:Mar.)
Page Start:: 161
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous. (17th March 2022)

Authors:: Lancelotta, Rafael
Journal:: Human psychopharmacology
Issue:: Volume 37:Number 3(2022)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy. Issue 4 (7th August 2020)

Authors:: Luoma, Jason B.; Chwyl, Christina; Bathje, Geoff J.; Davis, Alan K.; Lancelotta, Rafael
Journal:: Journal of psychoactive drugs
Issue:: Volume 52:Issue 4(2020)
Page Start:: 289
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N, N‐dimethyltryptamine (5‐MeO‐DMT). Issue 1 (8th March 2022)

Authors:: Reckweg, Johannes T.; Uthaug, Malin V.; Szabo, Attila; Davis, Alan K.; Lancelotta, Rafael; Mason, Natasha L.; Ramaekers, Johannes G.
Other Names:: Nichols Charles guestEditor.; Nichols David guestEditor.
Journal:: Journal of neurochemistry
Issue:: Volume 162:Issue 1(2022)
Page Start:: 128
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. (July 2018)

Authors:: Davis, Alan K; Barsuglia, Joseph P; Lancelotta, Rafael; Grant, Robert M; Renn, Elise
Journal:: Journal of psychopharmacology
Issue:: Volume 32:Number 7(2018)
Page Start:: 779
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. (March 2022)

Authors:: Uthaug, Malin Vedøy; Davis, Alan K; Haas, Trevor Forrest; Davis, Dawn; Dolan, Sean B; Lancelotta, Rafael; Timmermann, Christopher; Ramaekers, Johannes G
Journal:: Journal of psychopharmacology
Issue:: Volume 36:Number 3(2022)
Page Start:: 309
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗